These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14519180)

  • 21. Benzodiazepines in Miami-Dade County, Florida driving under the influence (DUI) cases (1995-1998) with emphasis on Rohypnol: GC-MS confirmation, patterns of use, psychomotor impairment, and results of Florida legislation.
    Raymon LP; Steele BW; Walls HC
    J Anal Toxicol; 1999 Oct; 23(6):490-9. PubMed ID: 10517556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of benzodiazepines and tribenzazolams by TRIAGE: confirmation by solid-phase extraction utilizing SPEC.3ML.MP3 microcolumns and GC-MS.
    Edinboro LE; Poklis A
    J Anal Toxicol; 1994 Oct; 18(6):312-6. PubMed ID: 7823538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay.
    Glover SJ; Allen KR
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):111-7. PubMed ID: 19969595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different immunoassays and GC-MS screening of benzodiazepines in urine.
    Augsburger M; Rivier L; Mangin P
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):681-7. PubMed ID: 9919969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance abuse monitoring by the Correctional Service of Canada.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2002 Feb; 24(1):187-91. PubMed ID: 11805743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.
    Haller CA; Stone J; Burke V; Branch J; Chen K; Gross S
    J Anal Toxicol; 2006 Mar; 30(2):106-11. PubMed ID: 16620541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of alcohol and other psychoactive substances in injured drivers: comparison between Belgium and The Netherlands.
    Legrand SA; Houwing S; Hagenzieker M; Verstraete AG
    Forensic Sci Int; 2012 Jul; 220(1-3):224-31. PubMed ID: 22483531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation into some aspects of EMIT d.a.u., TLC, and GC-MS urinalysis of bromazepam.
    El-Haj BM; Al-Amri AM; Hassan MH; Bin-Khadem RK
    J Anal Toxicol; 2001; 25(5):316-22. PubMed ID: 11499884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol and drugs use among drivers injured in road accidents in Campania (Italy): A 8-years retrospective analysis.
    Carfora A; Campobasso CP; Cassandro P; Petrella R; Borriello R
    Forensic Sci Int; 2018 Jul; 288():291-296. PubMed ID: 29793195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved CEDIA benzodiazepine assay eliminates sertraline crossreactivity.
    Fitzgerald RL; Herold DA
    J Anal Toxicol; 1997; 21(1):32-5. PubMed ID: 9013289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast gas chromatography-negative-ion chemical ionization mass spectrometry with microscale volume sample preparation for the determination of benzodiazepines and alpha-hydroxy metabolites, zaleplon and zopiclone in whole blood.
    Gunnar T; Ariniemi K; Lillsunde P
    J Mass Spectrom; 2006 Jun; 41(6):741-54. PubMed ID: 16645997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
    Krotulski AJ; Mohr ALA; Friscia M; Logan BK
    J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine findings in blood and urine by gas chromatography and immunoassay.
    Rasanen I; Neuvonen M; Ojanperä I; Vuori E
    Forensic Sci Int; 2000 Aug; 112(2-3):191-200. PubMed ID: 10940604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.